Clinical Trial Readiness for the Dystroglycanopathies

Recruiting now

Conditions studied: Muscular Dystrophy

In brief

The purpose of the study is to describe the early signs and symptoms of the dystroglycanopathies, and to gather information that will be required for future clinical trials.

Key facts

Study ID

NCT00313677

Run by

Katherine Mathews

People needed

190

Starts

2006-04-01

Expected to finish

2030-07-01

Last updated by the study team

2025-07-30

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Elevated CK (creatine kinase)
• Evidence of a dystroglycanopathy as determined by review of muscle pathology OR documented mutation in one of the known genes OR abnormal alpha-dystroglycan glycosylation in cultured fibroblasts
• Dystroglycanopathies are predicted to affect all racial and ethnic backgrounds, and all patients with dystroglycanopathies will be eligible for participation.
• Participants may be of any age, including children, and males and females will be recruited equally.
• Patients will have varying degrees of muscular weakness, but otherwise should be in relatively good health.

You may not qualify if…

• There are no exclusion criteria.

Where it is running

• University of Iowa, 200 Hawkins Drive — Iowa City, Iowa, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.